As key players in biological processes, glycans are essential to biomedical innovation and much small molecule drug manufacturing. Asymchem’s Chemical Macromolecule Division (CMMD) glycans technology platform provides custom glycans development and manufacturing of these key components including dextran, cyclodextrin derivatives, and dextran/metal complexes. Coupled with our peptide, oligonucleotide, polymer, and biotransformation capabilities, this allows access to oligosaccharides, peptidoglycans, and an ever-expanding range of drug conjugates.
To date, Asymchem’s glycans offerings have supported drug delivery systems, medical devices and excipients. We have the capacity to produce GMP product from grams to multi-kilograms. Our team can provide expert documentation preparation service to support IND/NDA filing.